A Multicenter Randomized Controlled Trial of a Digital Health Intervention for Medication Optimization in Heart Failure: The ENGAGE-HF Trial Outcomes
Circulation: Heart Failure · 08.11.2026
DOI: 10.1161/circheartfailure.126.015192 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Circulation: Heart Failure, online erschienen am 08.11.2026. Verfasst von Michael P Dorsch und 20 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, University of Michigan, Ann Arbor, MI; Frankel Cardiovascular Center, University of Michigan, Ann Arbor, MI. Gefördert von: American Heart Association.
Abstract (Originalsprache)
Background
Despite clear evidence that guideline-directed medical therapy (GDMT) significantly reduces mortality and hospitalizations in patients with heart failure (HF) with reduced and mildly reduced ejection fraction, real-world implementation remains suboptimal. Digital health interventions may promote GDMT titration after hospital discharge.
Methods
The ENGAGE-HF trial was a multicenter, two-arm, open-label, randomized controlled trial across three academic centers, funded by the AHA Strategically Focused Research Network (SFRN) for Health Technology and Innovation. Patients recently hospitalized with HF, with or without a primary hospital diagnosis of HF, and LVEF
Autor:innen und Institutionen
- College of Pharmacy, University of Michigan, Ann Arbor, MI; Frankel Cardiovascular Center, University of Michigan, Ann Arbor, MI.
- Division of Cardiology, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD.
- Division of Cardiology, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD; School of Nursing, Johns Hopkins University, Baltimore, MD.
- School of Medicine, Stanford University, Palo Alto, CA.
- School of Public Health, Boston University, Boston, MA.
- Division of Cardiovascular Medicine, Department of Internal Medicine, Medical School, University of Michigan, Ann Arbor, MI.
Förderung
- American Heart Association
Zitieren
APA
Dorsch, M. P., Gilotra, N. A., Spaulding, E. M., Martin, S. S., Zhao, H., Wilson, G. A., Poddar, M., Verma, A., Schmiedmayer, P., Kraft, P., Rodriguez, F., Azizi, Z., Hwang, P. H., Trumpower, B., Ganai, S., Basu, T., Luff, E., O'Neill, M., Nallamothu, B. K., …, & Sandhu, A. T. (2026). A Multicenter Randomized Controlled Trial of a Digital Health Intervention for Medication Optimization in Heart Failure: The ENGAGE-HF Trial Outcomes. Circulation: Heart Failure. https://doi.org/10.1161/circheartfailure.126.015192
Vancouver
Dorsch MP, Gilotra NA, Spaulding EM, Martin SS, Zhao H, Wilson GA, et al. A Multicenter Randomized Controlled Trial of a Digital Health Intervention for Medication Optimization in Heart Failure: The ENGAGE-HF Trial Outcomes. Circulation: Heart Failure. 2026. doi:10.1161/circheartfailure.126.015192
BibTeX
@article{Dorsch2026,
author = {Dorsch, Michael P and Gilotra, Nisha A and Spaulding, Erin M and Martin, Seth S and Zhao, Henry and Wilson, Grant A and Poddar, Manvi and Verma, Aradhana and Schmiedmayer, Paul and Kraft, Paul and Rodriguez, Fatima and Azizi, Zahra and Hwang, Phillip H and Trumpower, Brad and Ganai, Sabah and Basu, Tanima and Luff, Evan and O'Neill, Margaret and Nallamothu, Brahmajee K and Golbus, Jessica R and Sandhu, Alexander T},
title = {A Multicenter Randomized Controlled Trial of a Digital Health Intervention for Medication Optimization in Heart Failure: The ENGAGE-HF Trial Outcomes},
journal = {Circulation: Heart Failure},
year = {2026},
doi = {10.1161/circheartfailure.126.015192}
}
EUVIMED